Breaking News

PCI Builds New Clinical Storage and Distribution Facility

December 3, 2013

Expands North American operations

Packaging Coordinators Inc. (PCI) began construction of a new stand-alone clinical storage and global distribution facility in Rockford, IL, near its current facility. The new 93,000 sq.-ft. facility will allow PCI to provide additional capacity for both storage and global distribution. Construction is expected to be completed in mid-2014.   

The new distribution facility will support ambient and cold chain storage of investigational medicines and will be DEA approved for storage of Schedule II-V controlled substances. Also, its close proximity to the airport offers convenient international access. PCI currently distributes clinical/investigational medicines to investigator sites around the world and industry trends show continued growth of clinical studies in emerging markets such as South America, Asia, Russia, and Eastern Europe.

“We are very excited about the opportunity to build out our distribution capabilities in support of business growth,” said Bob Misher, senior vice president of Global Clinical Services at PCI. “The ability to package, store, globally distribute, and process returns of investigational medicines all in one state-of-the-art campus is a real benefit to our clients. This new facility helps us strategically position our business to further support industry trends we are witnessing; the first being international growth in the execution of our clients’ clinical studies, and the second being clients’ investigational medicines needing Cold Chain storage and shipment at 2-8°C, -20°C, and -80°C. We have been steadily expanding our capabilities in these areas as industry dynamics change. The location is built to be very accommodating as the industry and the needs of our clients evolve in years to come.”

Related Contract Manufacturing:

Related Packaging:

blog comments powered by Disqus
  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision

  • The Impact of Sample Handling  and Processing on the Outcome of Bioanalytical Testing

    The Impact of Sample Handling and Processing on the Outcome of Bioanalytical Testing

    Haiko Pillu, Head Technical Operations, Life Science Services, SGS Belgium NV||September 8, 2016
    Optimizing bioanalytical procedures to get reliable results in clinical studies

  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture